Prostate cancer is surprising difficult to keep alive outside the human body. Yet, like a greenhouse full of rare plants, the Melbourne Urological Research Alliance (MURAL) has cultivated a new collection of living patient tumours. By carefully studying the way these tumours grow, the MURAL consortium has identified promising drug targets for aggressive prostate cancer.

Researchers in Melbourne have developed a better way to test novel treatments for men with advanced prostate cancer. The research, lead by Professor Gail Risbridger at Monash University’s Biomedicine Discovery Institute and the Peter MacCallum Cancer Centre involves using laboratory grown tumours derived from patients to test which drugs are most effective for prostate cancer. Research scientist Dr Mitchell Lawrence stated that “These lab-grown tumours have enabled us to rapidly compare different treatments and identify those that cause the most striking reduction in tumour growth”. To read more about this important research please click here.




It’s the end of the year once again! On behalf of the Executive Director, Executive Committee, BioResource Management Committee, the Project Manager and the Node Coordinators, we would like to take this opportunity to extend our sincere appreciation to everyone who has supported the APCB this year. We would especially like to thank the urologists, pathologists, researchers, financial supporters and importantly, the donors of the tissue bank. We have collected over 150,000 samples from more than 6,000 men over the past 9 years and have distributed more than 8,500 samples to enable over 100 research programs. This wouldn’t have been possible without the dedication of everyone involved with the APCB. Best Wishes for the Holiday Season.

We look forward to a wonderful 2016! Add New

APCB poster ISBER 2015

The annual ISBER conference was held at the Sheraton Phoenix Downtown in Phoenix Arizona in May this year.  The meeting brings together biorepository operators, scientists, consultants and vendors in the only global forum which covers a broad range of biorepository-related issues and collection types. Topics discussed this year at the meeting included Return of Incidental Findings, Dynamic Consent, Trends in Biobanking Informatics and Biobanking Sustainability.

The meeting was attended by SA node coordinator, Ms Pam Saunders, who represented the APCB at the meeting’s poster session (click here for presented poster). Ms Saunders stated that the meeting was ‘a perfect forum for dissemination of ideas amongst new and old colleagues, the ability to access the latest related trends in software and hardware and return to our work places with the latest knowledge to optimise our procedures and protocols.’ The next ISBER meeting will be held in April 2016 in Berlin, Germany. The APCB hopes to attend this meeting next year.


Distinguished Professor Judith Clements

Executive Director of the APCB, Distinguished Professor Judith Clements, received the ‘Companion to the Order of Australia’ award as part of the Queen’s Birthday Celebrations last month. The award is the highest honour given over the Queen’s Birthday weekend. Distinguished Professor Clements was recognised for her outstanding contribution to Prostate and Ovarian Cancer research and for her role as executive director and founding partner of the APCB. Please click here and here for full access to the interview by Professor Clements.…

The Brisbane Node of the APCB was in the news last month. Executive Director, Distinguished Professor Judith Clements, talked about the lack of funding available to scientists working on prostate cancer research, specifically scientists involved in the APCB consortium. The news feed highlights the need for additional funds to keep the APCB functioning at a national level beyond June this year. Click here to access the news feed.…

Continue reading Continue reading